<DOC>
	<DOCNO>NCT00767221</DOCNO>
	<brief_summary>The study investigate effect PL-56 albumin leakage renal function ( glomerular filtration rate ) patient IgA nephropathy . It also assess safety treatment PL-56 .</brief_summary>
	<brief_title>Oral Treatment With PL-56 Patients With IgA Nephropathy - Explorative Study</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Signed informed consent Female male patient &gt; 18 year Biopsyverified IgA nephropathy Proteinuria : Ualbumin &gt; 500 mg/24 h Screatinine &lt; 200 umol/L A minimum four available sample result ( Ualbumin Screatinine ) prior inclusion study . Severe gastrointestinal disorder may impair drug effect , condition could modify effect trial drug judge investigator Consumption investigational drug within 30 day prior enrolment Unacceptable blood pressure ( treat untreated ) , define systolic value &gt; 150 mm Hg and/or diastolic &gt; 90 mm Hg Hyperlipidaemia define unacceptable level lipid accord discretion Investigator Patients ACE inhibitor introduced/changed last three month prior enrolment Patients treat immunosuppressive drug Patients unable take oral medication Severe liver disease ( define ASAT and/or ALAT and/or gammaGT twice normal value ) . Uncontrolled ( treat untreated ) congestive heart failure judge Investigator Patients diabetes Patients current malignancy history malignancy last three year History presence psychological psychiatric illness may interfere patientÂ´s ability adhere protocol Alcohol drug abuse ( present ) Patients unwilling meet requirement protocol Other medical social reason exclusion discretion Investigator Use drug inhibit cytochrome P450 enzyme CYP3A4 ( include grape fruit juice ) Kidney transplant patient For woman : pregnant breast feeding ; unwilling use adequate contraception study ( woman childbearing potential )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>